PI2.MU Stock Analysis
PI
Uncovered
Proteome Sciences PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. The company is headquartered in Addlestone, Surrey and currently employs 27 full-time employees. The services enable drug discovery, development and biomarker identification, and employ workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. The company uses high sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are its unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using super-depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents which are sold for multiplex quantitative proteomics.